Cargando…

Comparative efficacy, safety and cost of oral Chinese patent medicines for rheumatoid arthritis: a Bayesian network meta-analysis

BACKGROUND: Rheumatoid arthritis (RA) is a common inflammatory disease with a substantial burden for society and economic worldwide. Chinese patent medicines (CPMs) have gained attention as alternative remedies due to they can exert the satisfactory therapeutic effects via holistic regulation. Curre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Dan, Lyu, Jin-tao, Zhang, Bing, Zhang, Xiao-meng, Jiang, Hao, Lin, Zhi-jian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7339567/ https://www.ncbi.nlm.nih.gov/pubmed/32631398 http://dx.doi.org/10.1186/s12906-020-03004-4

Ejemplares similares

Comparative efficacy and safety of traditional Chinese patent medicine for endometriosis: A Bayesian network meta-analysis protocol
por: Dong, Shuangqian, et al.
Publicado: (2019)

Effectiveness and Safety of Oral Chinese Patent Medicines Combined with Chemotherapy for Gastric Cancer: A Bayesian Network Meta-Analysis
por: Lu, Xiaona, et al.
Publicado: (2020)

The clinical benefits of Chinese patent medicines against COVID-19 based on current evidence
por: Zhang, Dan, et al.
Publicado: (2020)

Traditional Chinese Patent Medicine for Primary Hypertension: A Bayesian Network Meta-Analysis
por: Chen, Zhe, et al.
Publicado: (2020)

Efficacy and Safety of Chinese Patent Medicine Combined With Oseltamivir in Treatment of Children With Influenza: A meta-Analysis
por: Duan, Nai-fan, et al.
Publicado: (2021)

Comparative efficacy and safety of traditional Chinese patent medicine for the treatment of type 2 diabetes mellitus: A Bayesian network meta-analysis protocol
por: Li, Jie, et al.
Publicado: (2020)

Comparative efficacy and safety of traditional Chinese patent medicine for endometriosis: A Bayesian network meta-analysis protocol: Erratum
Publicado: (2019)

Comparison of efficacy and safety of traditional Chinese patent medicines for diabetic nephropathy: A protocol for Bayesian network meta-analysis
por: Liu, Shilin, et al.
Publicado: (2022)

Efficacy and Safety of Oral Chinese Patent Medicine Combined with Conventional Therapy for Heart Failure: An Overview of Systematic Reviews
por: Lin, Shan-Shan, et al.
Publicado: (2020)

Efficacy and Safety of Tofacitinib in Chinese Patients with Rheumatoid Arthritis
por: Li, Zhan-Guo, et al.
Publicado: (2018)

Efficacy and safety of Chinese patent medicine compound preparation combined with routine treatment in vitiligo: A Bayesian network meta-analysis
por: Wang, Jianfeng, et al.
Publicado: (2023)

Efficacy and safety of different doses of baricitinib for rheumatoid arthritis: A Bayesian network meta-analysis
por: Haikun, Wang, et al.
Publicado: (2022)

Effectiveness comparisons of Chinese patent medicine on insomnia: A protocol for systematic review and Bayesian network meta-analysis
por: Chao, Ruoyu, et al.
Publicado: (2021)

Comparative efficacy and safety of traditional Chinese patent medicine for NAFLD in childhood or adolescence: A protocol for a Bayesian network meta analysis
por: Sun, Yuli, et al.
Publicado: (2021)

Comparative Efficacy and Safety of Chinese Patent Medicines for Cervical High-risk Human Papillomavirus Infection: A Bayesian Network Meta-analysis
por: Bin, Chengli, et al.
Publicado: (2023)

Effectiveness comparisons of Chinese patent medicine on sciatica: A protocol for systematic review and Bayesian network meta-analysis
por: An, Hongqiang, et al.
Publicado: (2020)

Efficacy and safety of oral traditional Chinese patent medicine in treatment of liver stagnation and spleen deficiency of depression: A protocol for systematic review
por: Yu, Ying, et al.
Publicado: (2020)

Efficacy and Safety of Integrated Traditional Chinese Medicine and Western Medicine on the Treatment of Rheumatoid Arthritis: A Meta-Analysis
por: Xing, Qi, et al.
Publicado: (2020)

Comparative efficacy of Chinese patent medicines in patients with carotid atherosclerotic plaque: a Bayesian network meta− analysis
por: Su, Wenquan, et al.
Publicado: (2023)

Treatment of Rheumatoid Arthritis with Traditional Chinese Medicine
por: Lee, Wen-Yuan, et al.
Publicado: (2014)

Comparative Efficacy of Oral Chinese Patent Medicine for Chronic Prostatitis/Chronic Pelvic Pain Syndrome With Sexual Dysfunction: A Bayesian Network Meta-Analysis of Randomized Controlled Trials
por: Zhang, Yang, et al.
Publicado: (2021)

Chinese patent medicines combined with hormone replacement therapy for premature ovarian failure: A Bayesian network meta-analysis
por: Zhong, Han-Zhi, et al.
Publicado: (2022)

Therapeutic effects and safety of oral Chinese patent medicine for COVID-19: A rapid systematic review and meta-analysis of randomized controlled trials
por: Liang, Shi-Bing, et al.
Publicado: (2021)

Clinical efficacy, safety, and cost of nine Chinese patent medicines combined with ACEI/ARB in the treatment of early diabetic kidney disease: A network meta-analysis
por: Liu, Jiarong, et al.
Publicado: (2022)

Where traditional Chinese medicine meets Western medicine in the prevention of rheumatoid arthritis
por: Jakobsson, Per‐Johan, et al.
Publicado: (2022)

The comparative effects of oral Chinese patent medicines in non-proliferative diabetic retinopathy: A Bayesian network meta-analysis of randomized controlled trials
por: Liu, Ziqiang, et al.
Publicado: (2023)

Comparative efficacy and safety of traditional Chinese patent medicine for cognitive dysfunction in diabetic cognitive dysfunction: A protocol for systematic review and Bayesian network meta-analysis
por: Wang, Kai, et al.
Publicado: (2022)

Efficacy and safety of Chinese patent medicine injection for COVID-19: A protocol for systematic review and meta-analysis
por: Lu, Meiqi, et al.
Publicado: (2020)

Chinese patent medicine for functional dyspepsia effects: A protocol for systematic review and Bayesian network meta-analysis
por: Wu, Jingjie, et al.
Publicado: (2021)

Effect and safety of oral Chinese patent medicine for heart failure: A protocol for systematic review and network meta-analysis
por: Guan, Hui, et al.
Publicado: (2020)

Efficacy and Safety of Qiwei Tongbi Oral Liquid in Patients with Stable Long-Standing Rheumatoid Arthritis
por: Lu, Wenjun, et al.
Publicado: (2021)

Efficacy and Safety of Chinese Patent Medicine for the Prevention and Treatment of Radiotherapy and Chemotherapy-Induced Oral Mucositis: A Systematic Review and Meta-Analysis
por: Xie, Yufei, et al.
Publicado: (2022)

Therapeutic effects and safety of oral Chinese patent medicine for COVID-19: A rapid systematic review and meta-analysis of randomized controlled trials
por: Liang, Shi-Bing, et al.
Publicado: (2021)

Traditional Chinese medicine for oral squamous cell carcinoma: A Bayesian network meta-analysis protocol
por: Wang, Dong, et al.
Publicado: (2020)

Efficacy and safety of traditional Chinese patent medicine on carotid artery atherosclerosis in adults: A network meta-analysis protocol
por: Sun, Huiqing, et al.
Publicado: (2021)

Network Pharmacology and Molecular Docking Study of the Chinese Miao Medicine Sidaxue in the Treatment of Rheumatoid Arthritis
por: Wu, Ning, et al.
Publicado: (2022)

Efficacy and safety of mavrilimumab in subjects with rheumatoid arthritis
por: Burmester, Gerd R, et al.
Publicado: (2013)

Oral proprietary Chinese medicine for lupus nephritis: A bayesian network meta-analysis
por: Lin, Aitao, et al.
Publicado: (2023)

Understanding Chinese Medicine Patterns of Rheumatoid Arthritis and Related Biomarkers
por: Seca, Susana, et al.
Publicado: (2018)

Clinical application of oral Chinese Patent Medicines in ophthalmology: a scoping review protocol
por: Xu, Kai, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qbu6nl58mblpbgaenflkcjr6ca